The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutic Pipeline Program, 2017Alternative Brain Stimulation Approach for the Treatment of Swallowing Impairment in Parkinson’s Disease
Study Rationale:
Dysphagia -- difficulty swallowing -- is common in people with advanced Parkinson's disease (PD). Dysphagia often leads to aspiration -- inhaling of food -- which can result in... -
Target Advancement Program, 2017Synapsin III as a Novel Therapeutic Target in Parkinson's Disease
Promising Outcomes of Original Grant:
Although the role of alpha-synuclein, the sticky protein that clumps in the cells of people with Parkinson's disease (PD), is not entirely clear, it is believed to... -
Research Grant, 2017A Study of Gastrointestinal Impairment in Parkinson's Disease
Study Rationale:
Gastrointestinal (GI) symptoms, such as constipation, nausea and vomiting, are common in Parkinson's disease (PD), but the cause of these symptoms is not entirely clear. Slow movement... -
Research Grant, 2017Studying Alpha-synuclein Oligomers Using Oligomer-binding Antibodies
Study Rationale:
Alpha-synuclein, the sticky protein that clumps in the cells of people with Parkinson's disease (PD), has long been implicated in the development of PD. Alpha-synuclein clumps vary in... -
LRRK2 Biology Consortium, 2017Developing a LRRK2-deactivating Vitamin for the Treatment of Parkinson’s Disease
Study Rationale:
One of the most common inherited causes of Parkinson’s disease (PD) is defect in the LRRK2 protein caused by changes, or mutations, of the LRRK2 gene. These LRRK2 mutations cause the... -
Research Grant, 2017Using Antibodies to Confirm Sticky Alpha-synuclein as the Cause of Parkinson's Disease
Study Rationale:
It is well known that the alpha-synuclein protein clumps in the cells of people with Parkinson's disease (PD), but it is unclear what prompts it to clump. Researchers believe that in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.